Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

What Are The Future Growth Projections For The Hematopoietic Stem Cell Transplantation Market Size?

There has been significant growth noted in the size of the hematopoietic stem cell transplantation market in the past few years. The market is projected to expand from a value of $4.68 billion in 2024 to $5.1 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 9.0%. Factors contributing to this growth during the historic period include the implementation of early transplantation methods, restricted indications and donor sources, advancements in conditioning protocols, the introduction of allogeneic transplants, and the achievement of regulatory milestones.

The market size of hematopoietic stem cell transplantation is anticipated to experience a significant surge in the coming years, with the prediction to reach $7.7 billion in 2029 through a compound annual growth rate (CAGR) of 10.8%. Factors contributing to this growth in the forecast period include the broadening scope of treatment indications, diversification of donor sources, developments in personalized medicine and genomics, alterations in regulations and guidelines, and market enlargement and accessibility. The forecast period is also characterized by major tendencies such as enhancements in transplantation methods, extension of indications, the rise of cellular therapies, donor diversification, and the implementation of a precision medicine approach.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10445&type=smp

Which Demand Drivers Are Strengthening The Hematopoietic Stem Cell Transplantation Market?

The rise in blood cancer prevalence is predicted to fuel the growth of the hematopoietic stem cell transplantation market. Blood cancer encompasses a variety of malignancies that interfere with the production and functioning of blood cells. Leukemia, lymphoma, and myeloma make up the primary forms of blood cancer. Hematopoietic stem cell transplantation is typically applied to address blood cancer, replacing malignant-killed stem cells and bone marrow cells. These new stem cells relocate to the bone marrow to create new blood cells, contributing to the growth of hematopoietic stem cell transplantation market. For example, Blood Cancer UK, a UK-based charity, reported in August 2022 that blood cancer is the sixth most common cancer in the UK, with 41,000 new cases identified annually. It’s estimated that blood cancer will affect 250,000 Britons in 2022, with one in 16 men and one in 22 women likely to be affected at some point. Moreover, blood cancer affects over 500 children under the age of 15 each year, including 400 with pediatric leukemia and 100 with lymphoma. Consequently, the surge in blood cancer prevalence propels the hematopoietic stem cell transplantation market.

What Segmentation Insights Are Provided In The Hematopoietic Stem Cell Transplantation Market Research?

The hematopoietic stem cell transplantationmarket covered in this report is segmented –

1) By Type: Allogeneic; Autologous

2) By Indication: Leukemia; Lymphatic Disorder; Myeloma; Other Non-Malignant Disorders

3) By Application: Bone Marrow Transplant; Peripheral Blood Stem Cell Transplant; Cord Blood Transplant

4) By End User: Hospital Pharmacy; Retail Pharmacy; Specialty Clinics

Subsegments:

1) By Allogeneic: Matched Related Donor Transplantation; Matched Unrelated Donor Transplantation; Cord Blood Transplantation

2) By Autologous: Peripheral Blood Stem Cell Transplantation; Bone Marrow Stem Cell Transplantation

Which Market Trends Are Expected To Define The Future Of The Hematopoietic Stem Cell Transplantation Market?

The gaining traction of product approvals is one leading trend in the hematopoietic stem cell transplantation market. To maintain a robust stand in the market, main players are turning towards the adoption of product authorizations. For example, in April 2022, Priothera Ltd., a late-stage biotech company based in Ireland, got approval for an investigational new drug (IND) from the US Food and Drug Administration (FDA) to start a Phase IIb/III trial of an allogeneic hematopoietic stem cell transplant (HSCT) using mocravimod in acute myeloid leukemia (AML) patients. Known as KRP203, mocravimod is a synthetic modulator of sphingosine 1-phosphate receptor (S1PR). This unique investigational drug’s safety, tolerability, and efficacy have been assessed in Phase I and Phase II trials for multiple autoimmune diseases.

Which Firms Are Driving Innovation Within The Hematopoietic Stem Cell Transplantation Market?

Major companies operating in the hematopoietic stem cell transplantation market include Pluristem Therapeutics Inc., Lonza Group AG, Escape Therapeutics Inc., Regen Biopharma Inc., Bluebird Bio Inc., CellGenix GmbH, CBR Systems Inc., Merck KGaA, Cord Blood Corporation, Kiadis Pharma NV, Marker Therapeutics Inc., Taiga Biotechnologies Inc., Takeda Pharmaceutical Company Limited, Talaris Therapeutics Inc., ViaCord LLC, ScienCell Research Laboratories Inc., BiolineRx, Stemcell Technologies Inc., ThermoGenesis Holdings Inc., MEDIPOST Co. Ltd., Anterogen. Co. Ltd., Pharmicell Inc., JCR Pharmaceuticals Co. Ltd., Holostem Terapie Avanzate Srl, Regrow Biosciences Pvt Ltd., Stempeutics Research Pvt Ltd.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/hematopoietic-stem-cell-transplantation-global-market-report

Which Regional Markets Are Emerging As Key Hubs For The Hematopoietic Stem Cell Transplantation Market?

North America was the largest region in the hematopoietic stem cell transplantation market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global hematopoietic stem cell transplantation market during the forecast period. The regions covered in the hematopoietic stem cell transplantation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=10445&type=smp

Browse Through More Reports Similar to the Global Hematopoietic Stem Cell Transplantation Market 2025, By The Business Research Company

Blood Glucose Meters Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/blood-glucose-meters-global-market-report

Blood Transfusion Diagnostics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/blood-transfusion-diagnostics-global-market-report

Patient Blood Management Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/patient-blood-management-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model